Expression of PSCA protein in human bladder urothelial cancer and its clinical significance

HE Ya-di,LI Liao-yuan,PAN Zhi-heng,XU You-yi,LIN Miao-xia,WANG Zi-ming,YU Chao,GAO Xin
DOI: https://doi.org/10.3877/cma.j.issn.1674-3253.2011.04.019
2011-01-01
Abstract:Objective To explore the expression of prostate stem cell antigen (PSCA) in bladder urothelial cancer and analyze its clinical significance and relationship with tumor recurrence.Methods The expressions of PSCA protein in 105 specimens of bladder cancer and 20 specimens of normal bladder tissues were detected by immunohistochemical staining and its clinical significance was then analyzed.Results The expression of PSCA protein was higher in bladder cancer than that in the adjacent normal tissues (P<0.05).PSCA protein expression rates were 23.1%,46.3%,and 76.0% in G 1,G 2,and G 3 tumors,respectively(P<0.001).Expression of PSCA protein was higher in muscle invasive bladder cancers than in non-muscle invasive bladder cancer (71.0% versus 47.3%,P=0.004).In patients with non-muscle invasive bladder cancer,PSCA protein expression was significantly higher in patients with recurrence than in those without recurrence (65.1% versus 32.3%,P<0.001).Conclusion PSCA may play a role in the development of bladder urothelial cancer.The determination of PSCA protein expression is potentially valuable in diagnosis and prognostic evaluation for bladder urothelial cancers.
What problem does this paper attempt to address?